Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Snider

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Blood Advances|June 3, 2026
Real-World Treatment Patterns of Patients with Large B-cell Lymphoma Over Time and into a Post-CAR T Approval EraMiguel-Angel Perales, Joseph P McGuirk, Mark R Fesen, et al.
JCO Oncology Practice|April 17, 2020
Comparison of Treatment, Cost, and Survival in Patients With Metastatic Colorectal Cancer in Western Washington, United States, and British Columbia, CanadaTodd A Yezefski, Dan Le, Leo Chen, et al.
JCO Clinical Cancer Informatics|March 17, 2022
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical PracticeCarsten Schröder, Craig Gower-Page, Irmarie Reyes-Rivera, et al.
Future Oncology (London, England)|August 31, 2021
Real-world association of HER2/<i>ERBB2</i> concordance with trastuzumab clinical benefit in advanced esophagogastric cancerStacey M Stein, Jeremy Snider, Siraj M Ali, et al.
JCO Precision Oncology|January 20, 2022
<i>ERBB2</i> Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal AdenocarcinomaLiangliang Zhang, Omar Hamdani, Ole Gjoerup, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2020
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profilingRussell Madison, Alexa B Schrock, Emily Castellanos, et al.
Chest|May 29, 2020
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort StudyAnish Thomas, Idrees Mian, Camille Tlemsani, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Blood Advances|June 3, 2026
Real-World Treatment Patterns of Patients with Large B-cell Lymphoma Over Time and into a Post-CAR T Approval EraMiguel-Angel Perales, Joseph P McGuirk, Mark R Fesen, et al.
JCO Oncology Practice|April 17, 2020
Comparison of Treatment, Cost, and Survival in Patients With Metastatic Colorectal Cancer in Western Washington, United States, and British Columbia, CanadaTodd A Yezefski, Dan Le, Leo Chen, et al.
JCO Clinical Cancer Informatics|March 17, 2022
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical PracticeCarsten Schröder, Craig Gower-Page, Irmarie Reyes-Rivera, et al.
Future Oncology (London, England)|August 31, 2021
Real-world association of HER2/<i>ERBB2</i> concordance with trastuzumab clinical benefit in advanced esophagogastric cancerStacey M Stein, Jeremy Snider, Siraj M Ali, et al.
JCO Precision Oncology|January 20, 2022
<i>ERBB2</i> Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal AdenocarcinomaLiangliang Zhang, Omar Hamdani, Ole Gjoerup, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2020
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profilingRussell Madison, Alexa B Schrock, Emily Castellanos, et al.
Chest|May 29, 2020
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort StudyAnish Thomas, Idrees Mian, Camille Tlemsani, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Pageof 3